This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Jeste, D. V. Articles by Zubenko, G. S. Search for Related Content PubMed PubMed Citation Articles by Jeste, D. V. Articles by Zubenko, G. S. Social Bookmarking                         What's this?

Research Agenda for DSM-V: Diagnostic Categories and Criteria for Neuropsychiatric Syndromes in Dementia

Division of Geriatric Psychiatry, Department of Psychiatry, University of California, San Diego, Stein Institute for Research on Aging, University of California, San Diego, djeste{at}ucsd.edu

Thomas W. Meeks, MD

Division of Geriatric Psychiatry, Department of Psychiatry, University of California, San Diego

Daniel S. Kim, MD

Division of Geriatric Psychiatry, Department of Psychiatry, University of California, San Diego

George S. Zubenko, MD, PhD

Department of Psychiatry, University of Pittsburgh

Neuropsychiatric symptoms in dementia represent a major health burden for older adults. These symptoms are often more distressing, impairing, and costly than cognitive symptoms in dementia, yet they have been less coherently categorized in the various versions of the Diagnostic and Statistical Manual of Mental Disorders (DSM). The preponderance of literature on psychiatric symptoms in dementia has been in patients with Alzheimer’s disease. Diagnostic criteria have been proposed for psychosis, depression, and sleep disturbance in Alzheimer’s disease. "Agitation" also appears to be a clinically important behavioral complication of dementia that warrants further study. Beginning with further validation of these proposed diagnostic criteria, future research can guide a more clinically meaningful description of these syndromes in DSM-V. Advancing biotechnology offers promise for discoveries related to the etiology and treatment of these syndromes. New research in this field should encompass diverse populations and different types of dementia. The high emotional and economic costs of neuropsychiatric symptoms in dementia implore diagnostic refinement to facilitate improved treatment. (J Geriatr Psychiatry Neurol 2006; 19:160-171)

Key Words: Alzheimer’s disease • dementia • psychosis • depression • sleep • agitation

Journal of Geriatric Psychiatry and Neurology, Vol. 19, No. 3, 160-171 (2006)
DOI: 10.1177/0891988706291087


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				T. W. Meeks, N. Lanouette, I. Vahia, S. Dawes, D. V. Jeste, and B. Lebowitz Psychiatric Assessment and Diagnosis in Older Adults Focus, January 1, 2009; 7(1): 3 - 16. [Abstract] [Full Text] [PDF]

				A. T. Blaszczyk and M. Mathys Treatment of Cognitive Decline and Psychiatric Disturbances Associated With Alzheimer's Dementia Journal of Pharmacy Practice, February 1, 2007; 20(1): 13 - 28. [Abstract] [PDF]